UnitedHealth Group (NYSE:UNH) Releases FY 2025 Earnings Guidance

by · The Cerbat Gem

UnitedHealth Group (NYSE:UNH – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 16.000- for the period, compared to the consensus EPS estimate of 16.230. The company issued revenue guidance of -.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $341.46 on Thursday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market cap of $309.25 billion, a PE ratio of 14.79, a PEG ratio of 2.22 and a beta of 0.45. The company’s 50 day moving average price is $294.30 and its two-hundred day moving average price is $367.06. UnitedHealth Group has a 12-month low of $234.60 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the previous year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts predict that UnitedHealth Group will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Analysts Set New Price Targets

UNH has been the subject of a number of research reports. Hsbc Global Res cut shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. HSBC restated a “reduce” rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Oppenheimer cut their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Royal Bank Of Canada cut their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Finally, Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $358.95.

Get Our Latest Stock Analysis on UNH

Institutional Trading of UnitedHealth Group

Several hedge funds have recently modified their holdings of UNH. Riggs Asset Managment Co. Inc. lifted its position in shares of UnitedHealth Group by 69.4% during the second quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 43 shares during the last quarter. Binnacle Investments Inc grew its stake in UnitedHealth Group by 185.8% in the 2nd quarter. Binnacle Investments Inc now owns 383 shares of the healthcare conglomerate’s stock valued at $119,000 after acquiring an additional 249 shares during the period. WFA of San Diego LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth $152,000. FJ Capital Management LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth $260,000. Finally, Darwin Wealth Management LLC acquired a new position in shares of UnitedHealth Group during the second quarter worth about $293,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More